These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 1706833)
21. Characteristics and early clinical outcomes of patients undergoing totally subcutaneous vs. transvenous single chamber implantable cardioverter defibrillator placement. Mithani AA; Kath H; Hunter K; Andriulli J; Ortman M; Field J; Russo AM Europace; 2018 Feb; 20(2):308-314. PubMed ID: 28383717 [TBL] [Abstract][Full Text] [Related]
22. Eligibility of Pacemaker Patients for Subcutaneous Implantable Cardioverter Defibrillators. Ip JE; Wu MS; Kennel PJ; Thomas G; Liu CF; Cheung JW; Markowitz SM; Lerman BB J Cardiovasc Electrophysiol; 2017 May; 28(5):544-548. PubMed ID: 28185354 [TBL] [Abstract][Full Text] [Related]
23. Sudden Cardiac Death Substrate Imaged by Magnetic Resonance Imaging: From Investigational Tool to Clinical Applications. Wu KC Circ Cardiovasc Imaging; 2017 Jul; 10(7):. PubMed ID: 28637807 [TBL] [Abstract][Full Text] [Related]
24. Early echocardiographic deformation analysis for the prediction of sudden cardiac death and life-threatening arrhythmias after myocardial infarction. Ersbøll M; Valeur N; Andersen MJ; Mogensen UM; Vinther M; Svendsen JH; Møller JE; Kisslo J; Velazquez EJ; Hassager C; Søgaard P; Køber L JACC Cardiovasc Imaging; 2013 Aug; 6(8):851-60. PubMed ID: 23850252 [TBL] [Abstract][Full Text] [Related]
25. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry. Amit G; Suleiman M; Konstantino Y; Luria D; Kazatsker M; Chetboun I; Haim M; Gavrielov-Yusim N; Goldenberg I; Glikson M; Europace; 2014 Aug; 16(8):1175-80. PubMed ID: 24554524 [TBL] [Abstract][Full Text] [Related]
26. Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy. Calkins H; Corrado D; Marcus F Circulation; 2017 Nov; 136(21):2068-2082. PubMed ID: 29158215 [TBL] [Abstract][Full Text] [Related]
27. [Experience with the use of an implantable automatic cardioverter defibrillator]. Dórticos F; Zayas R; Dorantes M; Tain J; Bueno J; Carballido J; Sainz H Arch Inst Cardiol Mex; 1990; 60(5):499-502. PubMed ID: 2091555 [TBL] [Abstract][Full Text] [Related]
29. The implantable cardioverter-defibrillator: An update. Miller JD; Yousuf O; Berger RD Trends Cardiovasc Med; 2015 Oct; 25(7):606-11. PubMed ID: 25912255 [TBL] [Abstract][Full Text] [Related]
30. Effect of elapsed time from coronary revascularization to implantation of a cardioverter defibrillator on long-term survival in the MADIT-II trial. Barsheshet A; Goldenberg I; Moss AJ; Huang DT; Zareba W; McNitt S; Klein HU; Guetta V J Cardiovasc Electrophysiol; 2011 Nov; 22(11):1237-42. PubMed ID: 21615813 [TBL] [Abstract][Full Text] [Related]
31. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Ellenbogen KA; Levine JH; Berger RD; Daubert JP; Winters SL; Greenstein E; Shalaby A; Schaechter A; Subacius H; Kadish A; Circulation; 2006 Feb; 113(6):776-82. PubMed ID: 16461817 [TBL] [Abstract][Full Text] [Related]
32. Impending sudden cardiac death: treatment with myocardial revascularization and the automatic implantable cardioverter defibrillator. Tyers GF Ann Thorac Surg; 1988 Jul; 46(1):1-2. PubMed ID: 3289512 [No Abstract] [Full Text] [Related]
33. [Implantable defibrillators. Clinical experience]. Mirowski M; Mower MM; Veltri EP; Juanteguy JM Ann Cardiol Angeiol (Paris); 1986 Dec; 35(10):589-95. PubMed ID: 3827149 [TBL] [Abstract][Full Text] [Related]
35. Reduced long-term overall mortality in heart failure patients with prolonged QRS treated with CRT combined with ICD vs. heart failure patients with narrow QRS treated with ICD only. Palmisano P; Accogli M; Pisanò EC; Zaccaria M; De Blasi S; Ponzetta MA; Valsecchi S; Milanese G; Lauretti M; Magliari F Europace; 2016 Sep; 18(9):1374-82. PubMed ID: 26612878 [TBL] [Abstract][Full Text] [Related]
36. Serum amine-based metabolites and their association with outcomes in primary prevention implantable cardioverter-defibrillator patients. Zhang Y; Blasco-Colmenares E; Harms AC; London B; Halder I; Singh M; Dudley SC; Gutmann R; Guallar E; Hankemeier T; Tomaselli GF; Cheng A Europace; 2016 Sep; 18(9):1383-90. PubMed ID: 26498162 [TBL] [Abstract][Full Text] [Related]
37. A critical appraisal of indications for the implantable cardioverter defibrillator (ICD). Cannom DS Clin Cardiol; 1992 May; 15(5):369-72. PubMed ID: 1623658 [TBL] [Abstract][Full Text] [Related]
38. Are the benefits of the automatic implantable cardioverter-defibrillator (AICD) overestimated by sudden death rate? Henthorn RW; Waller TJ; Hiratzka LF J Am Coll Cardiol; 1991 Jun; 17(7):1593-4. PubMed ID: 2033192 [No Abstract] [Full Text] [Related]
39. Implantable cardioverter-defibrillator therapy before death: high risk for painful shocks at end of life. Kinch Westerdahl A; Sjöblom J; Mattiasson AC; Rosenqvist M; Frykman V Circulation; 2014 Jan; 129(4):422-9. PubMed ID: 24243857 [TBL] [Abstract][Full Text] [Related]